MedPath

OxyContin Neo

Brand Name: OxyContin Neo

Generic Name: Oxycodone hydrochloride

Active
Registration Number

DR-XY45708

Dosage Form

Controlled-Release Tablet

Issuance Date

October 26, 2021

Expiry Date

December 15, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength40mg
PackagingAlu/Clear PVC/PVDC Blister Pack x 10's (Box of 20's, 30's and 40's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Opioid Analgesic
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Oxycodone hydrochlorideActive
Monograph: Oxycodone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform